Amedeo Smart

Free Medical Literature Service



Chronic Renal Failure

  Free Subscription

Articles published in
    March 2024
  1. WONG K, Pitcher D, Braddon F, Downward L, et al
    Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
    Lancet. 2024;403:1279-1289.
    >> Share

    January 2024
  2. KEARNEY N, Stefanovic N, Roche M
    Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient.
    Lancet. 2024;403:e1.
    >> Share

    December 2023
  3. TUTTLE KR, Hauske SJ, Canziani ME, Caramori ML, et al
    Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
    Lancet. 2023 Dec 15:S0140-6736(23)02408-X. doi: 10.1016/S0140-6736(23)02408.
    >> Share

    November 2023
  4. HEERSPINK HJL, Kiyosue A, Wheeler DC, Lin M, et al
    Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
    Lancet. 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230.
    >> Share

  5. ROVIN BH, Barratt J, Heerspink HJL, Alpers CE, et al
    Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
    Lancet. 2023 Nov 2:S0140-6736(23)02302-4. doi: 10.1016/S0140-6736(23)02302.
    >> Share

    August 2023
  6. HASSAN HA, Hafez MH, Luyckx VA, Tuglular S, et al
    Kidney failure in Sudan: thousands of lives at risk.
    Lancet. 2023;402:607.
    >> Share

    March 2023
  7. LUNDBERG S, Bergen K
    We can go further in non-immunosuppressive treatment of IgA nephropathy.
    Lancet. 2023 Mar 31:S0140-6736(23)00630-X. doi: 10.1016/S0140-6736(23)00630.
    >> Share

    January 2023
  8. BUDDE K, Halleck F
    Six pills less: no benefit for bicarbonate supplementation in renal allograft recipients.
    Lancet. 2023 Jan 25:S0140-6736(22)02630-7. doi: 10.1016/S0140-6736(22)02630.
    >> Share

  9. KOVALCHUK B, Khoramnia R
    Focusing on the eye signs of Alport syndrome in a 40-year-old man who previously had a kidney transplant and hearing loss.
    Lancet. 2023;401:e1.
    >> Share

    November 2022
  10. SELBY NM, Taal MW
    Evaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?
    Lancet. 2022;400:1657-1659.
    >> Share

  11. MARK PB, Sattar N
    Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02164.
    >> Share

    September 2022
  12. FAUCON AL, Messai N, Pardon A
    A sweet unilateral pleural effusion: pleuro-peritoneal communication in a patient on dialysis.
    Lancet. 2022;400:920.
    >> Share

    January 2022
  13. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016